Each week we highlight five things affecting the life sciences industry. Here’s the latest.
New python device enhances rotator cuff surgery outcomes
- A novel device inspired by the python’s ability to exert pressure has been developed to improve the success rates of rotator cuff surgeries by better securing tendons to bone.
- Per Science News, this innovation could significantly reduce recovery time and improve overall surgical outcomes, offering a promising advancement in orthopedic procedures.
Lawmakers attempt to block DTC drug ad tax deductions again
- U.S. lawmakers are making another attempt to prohibit tax deductions for direct-to-consumer (DTC) drug advertisements, a measure that has repeatedly failed in the past.
- Fierce Pharma reports that proponents argue that eliminating these deductions could reduce drug prices and encourage more responsible advertising, while opponents say it could stifle important consumer information.
FDA reorganizes CDRH communication offices
- The FDA has restructured the Center for Devices and Radiological Health (CDRH) to enhance coordination and improve communication strategies, combining several offices into a single unit.
- Per MedTech Dive, the reorganization aims to streamline operations and better support the center’s mission of ensuring the safety and effectiveness of medical devices.
INCOG to expand sterile injectables manufacturing
- INCOG BioPharma is set to expand its sterile injectables manufacturing capacity with a $100 million investment in a new facility, aimed at meeting growing demand for injectable drugs.
- Per World Pharmaceuticals, the expansion will increase production capabilities and offer flexible manufacturing solutions for a variety of formulations, supporting the company’s growth and service to clients.
Ozempic tied to lower risk of dementia and nicotine misuse: Study
- A recent study indicates that Ozempic, a popular weight-loss drug, may be associated with a reduced risk of developing dementia and a decreased likelihood of nicotine misuse, reports BioSpace.
- The research highlights potential additional benefits of Ozempic beyond weight management, suggesting its broader impact on brain health and addiction behaviors.
For more insights in life sciences, check out RSM’s industry outlook.
